The Brigham Intensive Review of Internal Medicine Question & Answer Companion (2nd Ed.)

Authors:

Language: English
Cover of the book The Brigham Intensive Review of Internal Medicine Question & Answer Companion

Subjects for The Brigham Intensive Review of Internal Medicine...

66.23 €

In Print (Delivery period: 14 days).

Add to cartAdd to cart
Publication date:
224 p. · 21.5x27.6 cm · Paperback

Based on the popular review course from Harvard Medical School, The Brigham Intensive Review of Internal Medicine Question & Answer Companion, 2nd Edition, provides more than 450 questions and in-depth answers on all specialties of internal medicine, as well as palliative care, occupational medicine, psychiatry, and geriatric medicine. Ideal for preparing for certification or maintenance of certification, this highly regarded review tool positions you for exam success!

Shares the knowledge and expertise of leading authorities from Harvard as well as former chief residents at Brigham and Women's Hospital.

  • Contains 450+ board review style questions with full discursive responses - all extensively revised to reflect current board standards.

  • Features a brand new, full-color design with all-new diagrams and color photos.

  • Provides thoroughly revised information throughout, with many new figures and updated tables.

  • Expert ConsultT eBook version included with purchase. This enhanced eBook experience allows you to search all of the text, figures, and references from the book on a variety of devices.

Brigham Q&A Companion

1. Infectious Diseases

2. Hematology and Oncology

3. Rheumatology

4. Pulmonary and Critical Care Medicine

5. Endocrinology

6. Nephrology and Hypertension

7. Gastroenterology

8. Cardiovascular Disease

9. General Internal Medicine

Dr. Singh has led groundbreaking studies in anemia of kidney disease, including the CHOIR study, which was published in the New England Journal of Medicine, and well as being a member of the steering committees for the TREAT and DRIVE studies. More recently, he has taken on the role of leading the ASCEND Clinical development program - a phase 3 program for the development of a novel propyl hydroxylase inhibitor Daprodustat. The trial is aiming to recruit 7500 patients in over countries. He currently leads the office of Postgraduate Medical Education at the Brigham and Women's Hospital, and in this capacity leads several HMS CME courses. He is the author of over 160 original contributions and review articles, as well as author/editor of 11 books in internal medicine and nephrology. Dr. Singh is a Fellow of the Royal College of Physicians in London, and has an MBA from Boston University.